Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06035549 · ClinicalTrials.gov registry record
Resilience in East Asian Immigrants for Advance Care Planning Discussions
A clinical trial of Neoplasms and Advance Care Planning, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- 84
- Enrollment target
- 1
- Study location
NCT06035549: Recruiting study of Neoplasms and Advance Care Planning, sponsored by University of Illinois at Chicago.
NCT06035549 is a study of Neoplasms and Advance Care Planning that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 84 participants, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06035549, a study of Neoplasms and Advance Care Planning, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to develop a culturally tailored digital resilience-building intervention to help East Asian immigrants engage in advance care planning discussions with their family caregivers.
Primary Outcome
Use the System Usability Scale (range: 0-100) to assess the usability of the intervention. Higher scores indicate greater perceived usability by users.
Conditions Studied
Interventions
- BEHAVIORAL Culturally Tailored Digital Resilience-Building
- BEHAVIORAL Semi-structured interviews
Study Locations (1)
Illinois
- University of Illinois Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2023-10-27 |
| Est. Completion | 2026-06-30 |
What NCT06035549 shows while recruiting
NCT06035549 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Culturally Tailored Digital Resilience-Building is the first listed.
NCT06035549 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06035549 about?
NCT06035549 is a clinical study titled "Resilience in East Asian Immigrants for Advance Care Planning Discussions". The purpose of the study is to develop a culturally tailored digital resilience-building intervention to help East Asian immigrants engage in advance care planning discussions with their family caregivers.
What is the current status of trial NCT06035549?
This trial is currently recruiting. The enrollment target is 84 participants. The study started on 2023-10-27. Estimated completion is 2026-06-30.
What conditions does trial NCT06035549 study?
This clinical trial studies the following conditions: Neoplasms, Advance Care Planning.
What interventions are being tested in trial NCT06035549?
The interventions under investigation include: Culturally Tailored Digital Resilience-Building (BEHAVIORAL), Semi-structured interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT06035549?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06035549 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06035549's enrollment target sits among peer trials
84 77th of 158 higher than 81 of 158 other Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RECRUITING · Phase 1
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
RECRUITING · Phase 1
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
RECRUITING · Phase 1
-
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI